IBDEI14U ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18388,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,18389,0)
 ;;=99213^^63^825^3
 ;;^UTILITY(U,$J,358.3,18389,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18389,1,1,0)
 ;;=1^Low MDM or 20-29 mins
 ;;^UTILITY(U,$J,358.3,18389,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,18390,0)
 ;;=99214^^63^825^4
 ;;^UTILITY(U,$J,358.3,18390,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18390,1,1,0)
 ;;=1^Moderate MDM or 30-39 mins
 ;;^UTILITY(U,$J,358.3,18390,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,18391,0)
 ;;=99215^^63^825^5
 ;;^UTILITY(U,$J,358.3,18391,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18391,1,1,0)
 ;;=1^High MDM or 40-54 mins
 ;;^UTILITY(U,$J,358.3,18391,1,2,0)
 ;;=2^99215
 ;;^UTILITY(U,$J,358.3,18392,0)
 ;;=99241^^63^826^1
 ;;^UTILITY(U,$J,358.3,18392,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18392,1,1,0)
 ;;=1^Problem Focused Hx/PE & SF MDM
 ;;^UTILITY(U,$J,358.3,18392,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,18393,0)
 ;;=99242^^63^826^2
 ;;^UTILITY(U,$J,358.3,18393,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18393,1,1,0)
 ;;=1^Exp Problem Focused Hx/PE & SF MDM
 ;;^UTILITY(U,$J,358.3,18393,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,18394,0)
 ;;=99243^^63^826^3
 ;;^UTILITY(U,$J,358.3,18394,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18394,1,1,0)
 ;;=1^Detailed Hx/PE & Low Complex MDM
 ;;^UTILITY(U,$J,358.3,18394,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,18395,0)
 ;;=99244^^63^826^4
 ;;^UTILITY(U,$J,358.3,18395,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18395,1,1,0)
 ;;=1^Comprehensive Hx/PE & Moderate Complex MDM
 ;;^UTILITY(U,$J,358.3,18395,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,18396,0)
 ;;=99245^^63^826^5
 ;;^UTILITY(U,$J,358.3,18396,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18396,1,1,0)
 ;;=1^Comprehensive Hx/PE & High Complex MDM
 ;;^UTILITY(U,$J,358.3,18396,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,18397,0)
 ;;=99024^^63^827^1
 ;;^UTILITY(U,$J,358.3,18397,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,18397,1,1,0)
 ;;=1^Post-Op Follow-Up Care
 ;;^UTILITY(U,$J,358.3,18397,1,2,0)
 ;;=2^99024
 ;;^UTILITY(U,$J,358.3,18398,0)
 ;;=R91.8^^64^828^2
 ;;^UTILITY(U,$J,358.3,18398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18398,1,3,0)
 ;;=3^Abnormal Finding of Lung Field
 ;;^UTILITY(U,$J,358.3,18398,1,4,0)
 ;;=4^R91.8
 ;;^UTILITY(U,$J,358.3,18398,2)
 ;;=^5019708
 ;;^UTILITY(U,$J,358.3,18399,0)
 ;;=R91.1^^64^828^101
 ;;^UTILITY(U,$J,358.3,18399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18399,1,3,0)
 ;;=3^Pulmonary Nodule,Solitary
 ;;^UTILITY(U,$J,358.3,18399,1,4,0)
 ;;=4^R91.1
 ;;^UTILITY(U,$J,358.3,18399,2)
 ;;=^5019707
 ;;^UTILITY(U,$J,358.3,18400,0)
 ;;=J85.2^^64^828^3
 ;;^UTILITY(U,$J,358.3,18400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18400,1,3,0)
 ;;=3^Abscess of Lung w/o Pneumonia
 ;;^UTILITY(U,$J,358.3,18400,1,4,0)
 ;;=4^J85.2
 ;;^UTILITY(U,$J,358.3,18400,2)
 ;;=^5008307
 ;;^UTILITY(U,$J,358.3,18401,0)
 ;;=J02.9^^64^828^76
 ;;^UTILITY(U,$J,358.3,18401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18401,1,3,0)
 ;;=3^Pharyngitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,18401,1,4,0)
 ;;=4^J02.9
 ;;^UTILITY(U,$J,358.3,18401,2)
 ;;=^5008130
 ;;^UTILITY(U,$J,358.3,18402,0)
 ;;=B20.^^64^828^1
 ;;^UTILITY(U,$J,358.3,18402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18402,1,3,0)
 ;;=3^AIDS (HIV Disease, HIV Stage 3, ARC)
 ;;^UTILITY(U,$J,358.3,18402,1,4,0)
 ;;=4^B20.
